Pharma channel feed

GSK re­fresh­es ‘Shin­gles doesn’t care’ cam­paign with fo­cus on hard­er-to-reach groups

Last year
Marketing

Marks re­hash­es Covid-19 ap­proval time­line, de­fends vac­cines for chil­dren at hear­ing

Last year
FDA+

Pfiz­er could end Lip­i­tor an­titrust saga in­volv­ing Ran­baxy with $93M set­tle­ment

Last year
Law

Will slow up­take of Leqem­bi pose a risk to Bio­gen’s re­cov­ery?

Last year

Eicos Sci­ences wins FDA ap­proval for first se­vere frost­bite treat­ment

Last year
FDA+

Biden ad­min­is­tra­tion tar­gets GPOs, whole­salers in re­quest for in­for­ma­tion on gener­ic short­ages

Last year
FDA+

Ap­peals court sides with As­traZeneca, BMS, McKesson in saxagliptin heart fail­ure case

Last year
Law

Sage 'en­cour­aged' by ini­tial Zurzu­vae sales in post­par­tum de­pres­sion, but no word on ma­jor de­pres­sion plans

Last year

SEC, DOJ sub­poe­na Bio­gen over Aduhelm launch and for­eign busi­ness op­er­a­tions

Last year

In­cyte is 'op­ti­mistic' about skin dis­ease drug Opzelu­ra as pre­scrip­tions grow 77% in Q4

Last year

FDA ap­proves Ipsen’s Onivyde as first-line treat­ment for type of pan­cre­at­ic can­cer

Last year
FDA+

Law­mak­ers call for US in­ves­ti­ga­tion of Chi­nese con­tract re­search gi­ants

Last year
Manufacturing

Mar­ket­ingRx roundup: Pfiz­er, Astel­las' Su­per Bowl spots; Lil­ly de­buts new Alzheimer’s ad

Last year
Marketing

Am­gen dou­bles down on ‘bad’ cho­les­terol aware­ness with new cam­paign, free test­ing

Last year
Marketing

Organon shelves con­tra­cep­tive with 'nat­u­ral' es­tro­gen

Last year
FDA+

Judge toss­es PhRMA's suit over drug price ne­go­ti­a­tions in a win for the Biden ad­min­is­tra­tion

Last year
Law

Stake­hold­ers brace for bumps in rare pe­di­atric dis­ease PRV reau­tho­riza­tion

Last year
FDA+

Neu­rol­o­gists val­ue speed and ef­fi­ca­cy over safe­ty for ALS pipeline drugs, study finds

Last year
Marketing

FTC re­view pe­ri­ods end for Ab­b­Vie-Im­muno­Gen $10.1B deal and $4B BMS-Rayze­Bio buy­out

Last year
Deals

Take­da wins long-await­ed US ap­proval for first oral drug for eosinophilic esophagi­tis

Last year
FDA+

FDA ad­dress­es ex­pand­ed use of da­ta mon­i­tor­ing com­mit­tees in draft guid­ance

Last year
FDA+

Gilead to snap up liv­er dis­ease biotech CymaBay for $4.3B

Last year
Deals

Pfiz­er joins Su­per Bowl ad line­up, toast­ing Katal­in Karikó and oth­er in­no­va­tors with 'Here’s to Sci­ence' spot

Last year
Marketing

No­vo Nordisk se­cures first two wins in le­gal bat­tle against com­pound­ing phar­ma­cies, well­ness cen­ters

Last year
Law
First page Previous page 73747576777879 Next page Last page
A service from the Financial Times